NCT02637635

Brief Summary

The purpose of this study is to determine if autologous fat transplantation as a pre-treatment gives better results in breast reconstruction with implants after mastectomy and radiotherapy. One group is randomized to conventional reconstruction with implant and one to pre-treatment prior reconstruction with implant. Our aims are:

  1. 1.To study whether lipofilling can decrease the number of reoperations and complications such as postoperative infections or not.
  2. 2.Evaluate the aesthetic results and the patients' experiences. For both these aims the hypothesis is that pre-treatment is in favour for the outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2014

Completed
1 year until next milestone

First Posted

Study publicly available on registry

December 22, 2015

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

April 17, 2019

Status Verified

April 1, 2019

Enrollment Period

7.3 years

First QC Date

December 22, 2014

Last Update Submit

April 15, 2019

Conditions

Keywords

MammaplastyTransplantation, AutologousMastectomyBreast ImplantsRadiotherapy, Adjuvant

Outcome Measures

Primary Outcomes (2)

  • Frequency of reoperations

    Two years on from reconstruction with prosthesis

  • Frequency of complications

    Two years on from reconstruction with prosthesis

Secondary Outcomes (4)

  • Total days in hospital during fat transplantation and reconstruction with prosthesis

    4 month

  • Number of appointments as outpatient after breast reconstruction.

    Two years on from reconstruction with prosthesis

  • Aesthetic evaluation of the results of the breast reconstruction

    Two years on from reconstruction with prosthesis

  • Patient reported outcome

    Measured at 6, 12 and 24 month from reconstruction with prosthesis

Study Arms (2)

Breast reconstruction with implant

EXPERIMENTAL

The patients will undergo breast reconstruction with an expander prosthesis.

Procedure: Expander prosthesis

Autologous fat transplantation

EXPERIMENTAL

The patients will undergo lipofilling as a pre-treatment before they will undergo breast reconstruction with an expander prosthesis.

Procedure: Autologous fat transplantationProcedure: Expander prosthesis

Interventions

100 ml of autologous fat will be injected to the reconstruction area 3 month prior the breast reconstruction with expander prosthesis.

Also known as: lipofilling, fat grafting, lipomodelling
Autologous fat transplantation

breast reconstruction with expander prosthesis.

Also known as: implant
Autologous fat transplantationBreast reconstruction with implant

Eligibility Criteria

Age25 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Previously undergone mastectomy and adjuvant radiotherapy.
  • Will undergo breast reconstruction with expander prosthesis.
  • Mammogram and ultrasound performed maximum three month prior surgery.
  • At least one year since last operation or radiotherapy.

You may not qualify if:

  • Known breast cancer relapse
  • Distant metastases except axillary
  • Any contraindication for anaesthesia
  • Systemic disease such as diabetes mellitus type I.
  • BMI \>30 (if the patients lose weight they are eligible)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet, Department of Molecular Medicine and Surgery, Karolinska University Hospital, Department of Reconstructive Plastic Surgery

Stockholm, 17177, Sweden

Location

Related Publications (4)

  • Serra-Renom JM, Munoz-Olmo JL, Serra-Mestre JM. Fat grafting in postmastectomy breast reconstruction with expanders and prostheses in patients who have received radiotherapy: formation of new subcutaneous tissue. Plast Reconstr Surg. 2010 Jan;125(1):12-18. doi: 10.1097/PRS.0b013e3181c49458.

    PMID: 20048576BACKGROUND
  • Rigotti G, Marchi A, Galie M, Baroni G, Benati D, Krampera M, Pasini A, Sbarbati A. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007 Apr 15;119(5):1409-1422. doi: 10.1097/01.prs.0000256047.47909.71.

    PMID: 17415234BACKGROUND
  • Sarfati I, Ihrai T, Kaufman G, Nos C, Clough KB. Adipose-tissue grafting to the post-mastectomy irradiated chest wall: preparing the ground for implant reconstruction. J Plast Reconstr Aesthet Surg. 2011 Sep;64(9):1161-6. doi: 10.1016/j.bjps.2011.03.031. Epub 2011 Apr 22.

    PMID: 21514910BACKGROUND
  • Mojallal A, Lequeux C, Shipkov C, Breton P, Foyatier JL, Braye F, Damour O. Improvement of skin quality after fat grafting: clinical observation and an animal study. Plast Reconstr Surg. 2009 Sep;124(3):765-774. doi: 10.1097/PRS.0b013e3181b17b8f.

    PMID: 19730294BACKGROUND

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Drug Implants

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Delayed-Action PreparationsDosage FormsPharmaceutical Preparations

Study Officials

  • Inkeri Schultz, PhD

    STUDY CHAIR
  • Åsa Edsander-Nord, Docent

    STUDY CHAIR
  • Marie Wickman Chantereau, Professor

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct professor

Study Record Dates

First Submitted

December 22, 2014

First Posted

December 22, 2015

Study Start

October 1, 2012

Primary Completion

January 1, 2020

Study Completion

January 1, 2020

Last Updated

April 17, 2019

Record last verified: 2019-04

Locations